{
    "Trade/Device Name(s)": [
        "Etest Ceftaroline"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K121002",
    "Predicate Device Reference 510(k) Number(s)": [
        "K102668"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY"
    ],
    "Summary Letter Date": "October 4, 2012",
    "Summary Letter Received Date": "October 5, 2012",
    "Submission Date": "March 30, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ceftaroline"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Quantitative antimicrobial susceptibility testing",
        "Agar gradient diffusion"
    ],
    "Methodologies": [
        "Minimum Inhibitory Concentration determination"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Etest Ceftaroline quantitative antimicrobial susceptibility testing reagent for Gram-negative and Gram-positive bacteria.",
    "Indications for Use Summary": "Quantitative determination of antimicrobial susceptibility of Gram-negative and Gram-positive aerobic and fastidious bacteria to ceftaroline using a predefined antibiotic gradient on agar media.",
    "fda_folder": "Microbiology"
}